Eli Lilly and Company Common Stock (LLY): Rumor News

LLY – Speculation of favorable patent ruling making the rounds.


Key Facts Surrounding This News Item


  • LLY had a POWR Rating of A (Strong Buy) coming into today.
  • LLY was 2.18% above its 10-Day Moving Average coming into today.
  • LLY was 3.86% above its 20-Day Moving Average coming into today.
  • LLY was 6.39% above its 50-Day Moving Average coming into today.
  • LLY was 6.91% above its 100-Day Moving Average coming into today.
  • LLY was 8.42% above its 200-Day Moving Average coming into today.
  • LLY had returned +20.56% year-to-date leading up to today’s news, versus a +14.87% return from the benchmark S&P 500 during the same period.

More Info About Eli Lilly and Company Common Stock (LLY)


Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company was founded in 1876 and is based in Indianapolis, Indiana. View our full LLY ticker page with ratings, news, and more.

LLY at a Glance

LLY Current POWR Rating™
Overall POWR Rating™
LLY Current Price $86.71 0.05%
More LLY Ratings, Data, and News

LLY Price Reaction

The day of this event (Oct. 5, 2017)
LLY Closing Price$87.10 0.79%
LLY Volume5,253,871
19.04% from avg
Leading up to this event
LLY 1-mo return8.95%
After this event
LLY 1-day return0.14%
LLY 3-day return0.93%
LLY 5-day return0.61%

LLY Price Chart



More Eli Lilly and Company Common Stock (LLY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All LLY News
Page generated in 0.9013 seconds.